Skip to main content
Medical information Clinical review pending

Infection Testing

Mycobacterium Combined Panel TBCOM Test

The Mycobacterium Combined Panel TBCOM Test helps diagnose tuberculosis (TB) by detecting the bacteria causing it using PCR, culture, and staining methods. Essential for individuals with TB symptoms or risk factors.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
First morning sputum (3 consecutive days), body fluids/aspirate (5-10 mL), CSF (2 mL), first morning urine (100 mL, 3 consecutive days), fresh tissue biopsies, whole blood or bone marrow (1-5 mL). Confirm specific requirements with the laboratory before booking.
Results
Interim results typically available within 14 days. Final results may take up to 6 weeks. Confirm exact turnaround time with the laboratory before booking.
Preparation
Follow specific collection instructions provided by the laboratory. For sputum samples, collect the first morning sample. Ensure aseptic collection for all specimens.
Test priceKSh 6,318

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Mycobacterium Combined Panel TBCOM Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Persistent cough (more than 3 weeks)
  • ✓Unexplained weight loss
  • ✓Night sweats
  • ✓Fever and chills
  • ✓Fatigue
  • ✓Close contact with a known TB patient
  • ✓Weakened immune system
  • ✓Living in a high TB prevalence area
02

In plain language

What this test helps you understand

This test is used to detect the presence of Mycobacterium Tuberculosis, the causative agent of tuberculosis (TB), aiding in the diagnosis and management of the disease.
The Mycobacterium Combined Panel TBCOM Test is a comprehensive diagnostic tool designed to detect Mycobacterium Tuberculosis, the bacterium responsible for tuberculosis (TB). This test utilizes advanced techniques such as PCR (Polymerase Chain Reaction), culture, and AFB (Acid-Fast Bacilli) staining to ensure accurate detection of TB in patients. Given the rising incidence of tuberculosis in various regions, early detection through this test is crucial for effective treatment and management.

This test measures the presence of Mycobacterium Tuberculosis in the body using the following methods: - Mycobacterium Tuberculosis PCR: A molecular technique that detects the genetic material of the bacteria. - Culture: A method that allows the bacteria to grow in a controlled environment for identification. - AFB Rapid Staining: A staining technique used to visualize the bacteria under a microscope.

This test is recommended for individuals exhibiting symptoms of tuberculosis, which may include a persistent cough lasting more than three weeks, unexplained weight loss, night sweats, fever and chills, or fatigue. Additionally, those with risk factors such as close contact with TB patients, weakened immune systems, or living in areas with high TB prevalence should consider getting tested.

Benefits of taking the test include early detection of tuberculosis, which is critical for effective treatment, helping to prevent the spread of TB to others, providing peace of mind, and guiding healthcare professionals in making informed treatment decisions.

Results from the Mycobacterium Combined Panel TBCOM Test are typically available within 14 days for interim results and up to 6 weeks for final results. A positive result indicates the presence of TB, while a negative result suggests that the bacteria were not detected. It is important to discuss your results with your healthcare provider to understand the implications and next steps.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationFollow specific collection instructions provided by the laboratory. For sputum samples, collect the first morning sample. Ensure aseptic collection for all specimens.
SampleFirst morning sputum (3 consecutive days), body fluids/aspirate (5-10 mL), CSF (2 mL), first morning urine (100 mL, 3 consecutive days), fresh tissue biopsies, whole blood or bone marrow (1-5 mL). Confirm specific requirements with the laboratory before booking.
MethodologyThe test employs a combination of methods including Mycobacterium Tuberculosis PCR (detects genetic material), Culture (grows bacteria for identification), and AFB Rapid Staining (visualizes bacteria under a microscope).
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
The test may not detect all forms of TB, especially in individuals with very low bacterial loads or certain types of TB. Results should be interpreted in conjunction with clinical findings and other diagnostic tests. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

This test detects the presence of Mycobacterium Tuberculosis, the bacteria that causes tuberculosis (TB), using PCR, culture, and staining methods.
Individuals with symptoms like persistent cough, weight loss, night sweats, fever, or fatigue, as well as those with risk factors like close contact with TB patients or weakened immunity, should consider testing.
Interim results are usually available within 14 days, while final results can take up to 6 weeks. Please confirm the current turnaround time with us.
Samples can include sputum, body fluids, urine, tissue biopsies, or blood. Specific requirements depend on the clinical situation; please consult your doctor or our lab.
Sample collection methods vary. Sputum collection involves coughing, while blood draws or biopsies may cause mild discomfort. Discuss concerns with your healthcare provider.
A positive result indicates the presence of TB bacteria. Your doctor will discuss the result with you, recommend further evaluation if needed, and initiate appropriate treatment.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp